• frame01
  • frame02
  • scale-up

E-mail Print

Process Chemistry Conferences Schedule

Event 

Title:
Organic Process Research and Development
Subtitle:
The Leading Process Chemistry Conference!
When:
19.03.2012 - 21.03.2012
Where:
Sheraton Fisherman's Wharf Hotel - San Francisco
Brochure:
View Brochure

Description

Do you want to improve efficiency and innovation in your synthetic route design, development and optimisation?

The efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance in the chemical and pharmaceutical industries. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently.

At Organic Process Research & Development Conference, you will hear detailed presentations and case studies from top international chemists. Our hand-picked programme of speakers has been put together specifically for an industrial audience. They will discuss the latest issues relating to synthetic route design, development and optimisation in the pharmaceutical, fine chemical and allied fields.

Unlike other conferences, practically all our speakers are experts from industry, which means the ideas and information you take home will be directly applicable to your own work.

The smaller numbers at our conferences create a more intimate atmosphere. You will enjoy plenty of opportunities to meet and network with speakers and fellow attendees during the reception, sit-down lunches and extended coffee breaks in a relaxed and informal environment. Together, you can explore the different strategies and tactics evolving to meet today’s challenges.

Who Should Attend?

  • Process Research & Development Chemists
  • Chemical Engineers in Industry
  • Heads of Departments & Team Leaders

  • Monday 19 March 2012 - Conference Day One

     08.15 Registration from 08.15
    Morning Session Chair: Dr Will Watson, Scientific Update, UK
     08.55 Opening Remarks
     09.00 Dr Lori Spangler, Bristol Myers Squibb, USA
    The Brivanib Alaninate Process: Route Selection and Process Development
     09.45 Dr Ayman Allian, Abbott Laboratories, USA
    The Development of Continuous Process for the Alkene Ozonolysis based on Combined in Situ FTIR Calorimetry and Computational Chemistry
     10.30 Coffee and Exhibition
     11.15 Dr Jade Nelson, Pfizer Worldwide, USA
    Process Chemistry at Pfizer: From Block Busters to Niche Market Drugs
     12.00 Dr Gjalt Huisman, Codexis, USA
    Biocatalytic Process Development for Clinical Candidates and Marketed Drugs: Aligning Technology with Process Needs
     12.45 Lunch and Exhibition kindly sponsored by
    Signa Chemistry
    Afternoon Session Chair: Dr Juergen Roos, Evonik Industries AG, Germany
     14.00 Dr William Goundry, Astra Zeneca, UK
    The Application of Design of Experiment: Case Studies from Process Development
     14.45 Dr Terry Kougoulos, Novan Therapeutics, USA
    Which Dryer to Choose for Scale-Up?
     15.30 Coffee and Exhibition
     16.15 Dr Dave Ager, DSM, USA
    So Many to Choose From: Have I Got the Right One
     17.00 Dr Brenda Burke, Gilead Sciences Inc, USA
    Practical Syntesis of a CXCR3 Inhibitor
     17.45 End of Day One
     17.45 Networking Reception
    - kindly sponsored by Evonik Industries
  • Tuesday 20 March 2012 - Conference Day Two

    Morning Session Chair: Dr Jay Srirangam, Pfizer, USA
    From  07.30 Breakfast in the Exhibition Room, kindly sponsored by The American Chemical Society
     08.25 Opening Remarks
     08.30 Dr Matthew Ball, AstraZeneca, UK
    Synthesis of Two Complex Heterocyclic API Frameworks without Metal Catalysed Coupling: New Route Introduction and Process Safety Aspects
     09.15 Dr Karen Sutherland, Pfizer, USA
    Fit for Purpose Development of a Scaleable Process to Vabicaserin
    10.00 Coffee and Exhibition
    10.45 Dr Joseph Martinelli, Eli Lilly & Co, USA
    Design and Development of a Large Scale EDCI-Mediated Amide Bond Forming Reaction
     11.30 Dr Jay Srirangam, Pfizer, USA
    Discussion
    How chemical development is evolving in pharma and how it is creating opportunity outside of pharma within the CROs.
     12.15 Lunch and Exhibition
     13.30 OPTIONAL SHORT COURSE
    Grignards in Process R&D

    Tutor: Dr Will Watson, Scientific Update This half day course will include a short introduction, practical considerations on the formation of Grignard reagents, solvent effects, safety issues and recent developments in the field of Grignard chemistry.
    16.30 End of Day Two
    18.30-21.00 Cocktail Reception hosted by Albemarle
    At Bistro Boudin's Bakery Museum at Fisherman's Wharf
  • Wednesday 21 March 2012 - Conference Day Three

    Morning Session Chair: Dr John Knight, Scientific Update, UK
    08.25 Opening Remarks
    08.30 Ms Susan Shilcrat, GlaxoSmithKline, USA
    Ensuring the Basis of Safety Throughout the Development Process
    09.15 Dr Conchita Fernandez Garcia, Almac Group, UK
    Development of an Efficient and Practical Route for the Multi-kilogram Manufacture of Cyanopyridone AZ10527409 and Chloropyridine AZ10146848
    10.00 Coffee and Exhibition
    10.45 Dr Xudong Wei, Boehringer Ingelheim, USA
    Development of Highly Efficient Manufacturing Routes to the HCV Protease Inhibitors
    11.30 Dr Jonathan Grote, Abbott Laboratories, USA
    Development of a Manufacturable Process for Methotrexate Conjugate Synthesis
    12.15 End of Conference
  • Networking Reception Sponsor

    evonik_web

    Day 1 Lunch Sponsor

    Signa Chemistry

    Cocktail Reception

    Albemarlecolor10cm

    Media Sponsors

    Wiley Publications PharmaChem Thieme Chemistry Today
    Sp2 ae_logo
      cheminddig
  • "Excellent conference - highly recommended."
    DuPont de Nemours & Co Inc

    "OPRD is a very well balanced, professionally organised conference, which not only provides the latest developments in process chemistry, but also provides opportunities for fellow scientists to interact in a professional way."
    Johnson Matthey

    "Scientific Update has done it once again.  They have provided a first class conference!"
    Aryx Therapeutics

    "Great opportunity to see real life working chemistry and for networking with colleagues, all in a very pleasant environment."
    Wyeth

    "Excellent conference! Speakers were well chosen with relevant content, the staff were extremely well organised, friendly and accommodating.  I'll recommend this event to my colleagues."
    US Army

 

Fee Information

Conference Fee:
$1995
Academic Fee:
$695
Exhibitor Fee:
$2995 for booth + attendee, $750 for extra attendees

Venue

Sheraton Fisherman's Wharf HotelMap
Venue:
Sheraton Fisherman's Wharf Hotel   -   Website
Street:
2500 Mason Street
Postcode / ZIP:
94133
City:
San Francisco
State:
California
Country:
Country: us

Description

The Sheraton Fisherman’s Wharf hotel is ideally situated in the heart of Fisherman’s Wharf, but only two blocks from San Francisco’s cable cars. It has 529 modern, well-equipped rooms. They all have individual air-conditioning and high speed internet access. There is a fully equipped business centre and fitness suite.

The hotel is holding standard rooms for us at a discounted rate. Full details of how to book your accommodation will be sent when you register.

Directions:

By Air: San Francisco Airport is 16 miles and Oakland Airport 20 miles. Please visit the hotel website for driving directions.